273 related articles for article (PubMed ID: 34168644)
1. lncRNA-HEIM Facilitated Liver Fibrosis by Up-Regulating TGF-
Yao J; Lin C; Jiang J; Zhang X; Li F; Liu T; Diao H
Front Immunol; 2021; 12():666370. PubMed ID: 34168644
[TBL] [Abstract][Full Text] [Related]
2. Huangqi Decoction, a compound Chinese herbal medicine, inhibits the proliferation and activation of hepatic stellate cells by regulating the long noncoding RNA-C18orf26-1/microRNA-663a/transforming growth factor-β axis.
Dong BS; Liu FQ; Yang WN; Li XD; Shi MJ; Li MR; Yan XL; Zhang H
J Integr Med; 2023 Jan; 21(1):47-61. PubMed ID: 36456413
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic value of LncRNA-MEG3 as a serum biomarker in patients with hepatitis B complicated with liver fibrosis.
Chen MJ; Wang XG; Sun ZX; Liu XC
Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4360-4367. PubMed ID: 31173310
[TBL] [Abstract][Full Text] [Related]
4. Activated hepatic stellate cells impair NK cell anti-fibrosis capacity through a TGF-β-dependent emperipolesis in HBV cirrhotic patients.
Shi J; Zhao J; Zhang X; Cheng Y; Hu J; Li Y; Zhao X; Shang Q; Sun Y; Tu B; Shi L; Gao B; Wang FS; Zhang Z
Sci Rep; 2017 Mar; 7():44544. PubMed ID: 28291251
[TBL] [Abstract][Full Text] [Related]
5. Identification of plasma lncRNA-ATB levels in hepatitis B virus-related cirrhosis and non-cirrhotic chronic hepatitis B patients.
Shoraka S; Mohebbi SR; Hosseini SM; Asadzadeh Aghdaei H; Zali MR
Virus Res; 2021 Oct; 303():198503. PubMed ID: 34331990
[TBL] [Abstract][Full Text] [Related]
6. Epigenetically-Regulated MicroRNA-9-5p Suppresses the Activation of Hepatic Stellate Cells via TGFBR1 and TGFBR2.
Yu F; Chen B; Fan X; Li G; Dong P; Zheng J
Cell Physiol Biochem; 2017; 43(6):2242-2252. PubMed ID: 29073595
[TBL] [Abstract][Full Text] [Related]
7. Role of LncRNA-activated by transforming growth factor beta in the progression of hepatitis C virus-related liver fibrosis.
Fu N; Niu X; Wang Y; Du H; Wang B; Du J; Li Y; Wang R; Zhang Y; Zhao S; Sun D; Qiao L; Nan Y
Discov Med; 2016 Aug; 22(119):29-42. PubMed ID: 27585228
[TBL] [Abstract][Full Text] [Related]
8. Physalin D attenuates hepatic stellate cell activation and liver fibrosis by blocking TGF-β/Smad and YAP signaling.
Xiang D; Zou J; Zhu X; Chen X; Luo J; Kong L; Zhang H
Phytomedicine; 2020 Nov; 78():153294. PubMed ID: 32771890
[TBL] [Abstract][Full Text] [Related]
9. LncRNA-ATB/microRNA-200a/β-catenin regulatory axis involved in the progression of HCV-related hepatic fibrosis.
Fu N; Zhao SX; Kong LB; Du JH; Ren WG; Han F; Zhang QS; Li WC; Cui P; Wang RQ; Zhang YG; Nan YM
Gene; 2017 Jun; 618():1-7. PubMed ID: 28302418
[TBL] [Abstract][Full Text] [Related]
10. Myeloid-derived suppressor cells induce regulatory T cells in chronically HBV infected patients with high levels of hepatitis B surface antigen and persist after antiviral therapy.
Pal S; Nandi M; Dey D; Chakraborty BC; Shil A; Ghosh S; Banerjee S; Santra A; Ahammed SKM; Chowdhury A; Datta S
Aliment Pharmacol Ther; 2019 May; 49(10):1346-1359. PubMed ID: 30982998
[TBL] [Abstract][Full Text] [Related]
11. Pathological Roles of Interleukin-22 in the Development of Recurrent Hepatitis C after Liver Transplantation.
Gao Y; Ren H; Meng F; Li J; Cheung E; Li H; Zhao J; Liu H; Liu Z; Zhang M
PLoS One; 2016; 11(4):e0154419. PubMed ID: 27123854
[TBL] [Abstract][Full Text] [Related]
12. TGF-β signaling is activated in patients with chronic HBV infection and repressed by SMAD7 overexpression after successful antiviral treatment.
Argentou N; Germanidis G; Hytiroglou P; Apostolou E; Vassiliadis T; Patsiaoura K; Sideras P; Germenis AE; Speletas M
Inflamm Res; 2016 May; 65(5):355-65. PubMed ID: 26856334
[TBL] [Abstract][Full Text] [Related]
13. Long non‑coding RNA MBI‑52 inhibits the development of liver fibrosis by regulating the microRNA‑466g/SMAD4 signaling pathway.
Li Y; Liu P; Wei F
Mol Med Rep; 2022 Jan; 25(1):. PubMed ID: 34850963
[TBL] [Abstract][Full Text] [Related]
14. Multifaceted Defects in Monocytes in Different Phases of Chronic Hepatitis B Virus Infection: Lack of Restoration after Antiviral Therapy.
Dey D; Pal S; Chakraborty BC; Baidya A; Bhadra S; Ghosh R; Banerjee S; Ahammed SKM; Chowdhury A; Datta S
Microbiol Spectr; 2022 Dec; 10(6):e0193922. PubMed ID: 36445121
[TBL] [Abstract][Full Text] [Related]
15. Key Anti-Fibrosis Associated Long Noncoding RNAs Identified in Human Hepatic Stellate Cell via Transcriptome Sequencing Analysis.
Li XQ; Ren ZX; Li K; Huang JJ; Huang ZT; Zhou TR; Cao HY; Zhang FX; Tan B
Int J Mol Sci; 2018 Feb; 19(3):. PubMed ID: 29495545
[TBL] [Abstract][Full Text] [Related]
16. [Association between CD4+CD25+Foxp3+ regulatory T cells and serum transforming growth factor beta 1 in patients with chronic hepatitis B].
Yang GL; Xu LM; Yao HY; Wang HS; Jiang XL; Li W; Wang M; Zhou BP
Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):831-4. PubMed ID: 19958642
[TBL] [Abstract][Full Text] [Related]
17. lncRNA GAS5 restrains CCl
Dong Z; Li S; Wang X; Si L; Ma R; Bao L; Bo A
Am J Physiol Gastrointest Liver Physiol; 2019 Apr; 316(4):G539-G550. PubMed ID: 30735452
[TBL] [Abstract][Full Text] [Related]
18.
Yan J; Hu B; Shi W; Wang X; Shen J; Chen Y; Huang H; Jin L
Am J Physiol Gastrointest Liver Physiol; 2021 May; 320(5):G720-G728. PubMed ID: 33728992
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B virus X protein promotes proliferation and upregulates TGF-beta1 and CTGF in human hepatic stellate cell line, LX-2.
Guo GH; Tan DM; Zhu PA; Liu F
Hepatobiliary Pancreat Dis Int; 2009 Feb; 8(1):59-64. PubMed ID: 19208517
[TBL] [Abstract][Full Text] [Related]
20. Telbivudine therapy may shape CD4(+) T-cell response to prevent liver fibrosis in patients with chronic hepatitis B.
Li J; Jia M; Liu Y; She W; Li L; Wang J; Jiang W
Liver Int; 2015 Mar; 35(3):834-45. PubMed ID: 24814578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]